Abstract

A cross-diagnostic, post-hoc analysis of the BRIDGE-II-MIX study was performed to investigate how unipolar and bipolar patients suffering from an acute major depressive episode (MDE) cluster according to severity and duration. Duration of index episode, Clinical Global Impression-Bipolar Version-Depression (CGI-BP-D) and Global Assessment of Functioning (GAF) were used as clustering variables. MANOVA and post-hoc ANOVAs examined between-group differences in clustering variables. A stepwise backward regression model explored the relationship with the 56 clinical-demographic variables available. Agglomerative hierarchical clustering with two clusters was shown as the best fit and separated the study population (n = 2314) into 65.73% (Cluster 1 (C1)) and 34.26% (Cluster 2 (C2)). MANOVA showed a significant main effect for cluster group (p < 0.001) but ANOVA revealed that significant between-group differences were restricted to CGI-BP-D (p < 0.001) and GAF (p < 0.001), showing greater severity in C2. Psychotic features and a minimum of three DSM-5 criteria for mixed features (DSM-5-3C) had the strongest association with C2, that with greater disease burden, while non-mixed depression in bipolar disorder (BD) type II had negative association. Mixed affect defined as DSM-5-3C associates with greater acute severity and overall impairment, independently of the diagnosis of bipolar or unipolar depression. In this study a pure, non-mixed depression in BD type II significantly associates with lesser burden of clinical and functional severity. The lack of association for less restrictive, researched-based definitions of mixed features underlines DSM-5-3C specificity. If confirmed in further prospective studies, these findings would warrant major revisions of treatment algorithms for both unipolar and bipolar depression.

Details

Title
Deconstructing major depressive episodes across unipolar and bipolar depression by severity and duration: a cross-diagnostic cluster analysis on a large, international, observational study
Author
Corponi Filippo 1   VIAFID ORCID Logo  ; Anmella Gerard 2   VIAFID ORCID Logo  ; Pacchiarotti Isabella 3 ; Samalin Ludovic 4 ; Verdolini Norma 5 ; Popovic, Dina 6 ; Jean-Michel, Azorin 7 ; Angst Jules 8 ; Bowden, Charles L 9 ; Mosolov Sergey 10   VIAFID ORCID Logo  ; Young, Allan H 11   VIAFID ORCID Logo  ; Perugi Giulio 12 ; Vieta Eduard 13   VIAFID ORCID Logo  ; Murru, Andrea 5   VIAFID ORCID Logo 

 University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758); University of Barcelona, IDIBAPS, CIBERSAM, Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain (GRID:grid.6292.f) 
 University of Barcelona, IDIBAPS, CIBERSAM, Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain (GRID:grid.6292.f) 
 University of Barcelona, IDIBAPS, CIBERSAM, Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain (GRID:grid.6292.f); Biomedical Research Networking Center for Mental Health (CIBERSAM), Barcelona, Spain (GRID:grid.6292.f); August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (GRID:grid.10403.36) 
 University of Barcelona, IDIBAPS, CIBERSAM, Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain (GRID:grid.10403.36) 
 University of Barcelona, IDIBAPS, CIBERSAM, Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain (GRID:grid.10403.36); Biomedical Research Networking Center for Mental Health (CIBERSAM), Barcelona, Spain (GRID:grid.10403.36); August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (GRID:grid.10403.36) 
 Chaim Sheba Medical Center, Psychiatry B, Ramat-Gan, Israel (GRID:grid.413795.d) (ISNI:0000 0001 2107 2845) 
 Sainte Marguerite Hospital, Department of Psychiatry, Marseille, France (GRID:grid.414438.e) (ISNI:0000 0000 9834 707X) 
 University of Zurich, Department of Psychiatry, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650) 
 University of Texas Health Science Center, Department of Psychiatry, San Antonio, USA (GRID:grid.267309.9) (ISNI:0000 0001 0629 5880) 
10  Moscow Research Institute of Psychiatry, Department for Therapy of Mental Disorders, Moscow, Russia (GRID:grid.473242.4) 
11  Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
12  University of Pisa, Clinica Psichiatrica, Pisa, Italy (GRID:grid.5395.a) (ISNI:0000 0004 1757 3729) 
13  University of Barcelona, IDIBAPS, CIBERSAM, Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain (GRID:grid.5395.a); Biomedical Research Networking Center for Mental Health (CIBERSAM), Barcelona, Spain (GRID:grid.5395.a); August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (GRID:grid.10403.36) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2424817327
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.